Finland's 3D imaging market is projected to grow from $0.06 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by rising demand for innovative medical technology, a strong emphasis on research and innovation, and public and private sector collaborations. The market is segmented by product, application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Disior.
Finland's 3D imaging market is projected to grow from $0.06 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The health expenditure (% of GDP) for Finland raised from 9.15% in 2018 to 9.2% in 2020 which is relatively higher than the average for European Union countries. In Finland, the public healthcare system, commonly known as universal healthcare, provides services to all citizens. In Finland, healthcare is paid through taxes and social security contributions. According to Statistics Finland's data on causes of death, disorders of the circulatory system, neoplasms, and memory problems caused the biggest number of fatalities in 2020. These disorders killed approximately 42,000 people.
3D Imaging provides a wide variety of uses and prospects in Finland's healthcare industry. Diagnostic imaging, such as computed tomography (CT) and magnetic resonance imaging (MRI) scans, is one of the most important uses of 3D Imaging in Finland. These scans may offer extremely detailed 3D representations of the body's interior components. In Finland, the potential for 3D Imaging is considerable, driven by rising demand for innovative medical technology and a strong emphasis on research and innovation. As technology continues to advance, 3D Imaging is likely to play an increasingly vital role in improving healthcare outcomes and advancing medical research in Finland.
Market Growth Drivers
In May 2022, Researchers in Finland devised a means to make medical imaging data three-dimensional (3D) and convey those to virtual reality (VR). A doctor may utilize this innovative technology to assess a patient's health issue, give a diagnosis, and even schedule surgeries using a VR headset. The market has consistently been strong in Finland, and the value of Finland's exports of healthcare technology goods increased by 3.6% to $2.7 Bn in 2021. (Healthtech Finland 2022). In addition, Finland has a significant R&D contribution to health and MedTech. Moreover, Finland invites firms to collaborate on worldwide expansion, stronger collaboration between the commercial and public sectors, and the continuous need for a multidisciplinary approach among organizations focusing on research, development, innovation, institutions of higher education, and businesses. These factors along with the rising frequency of chronic diseases and increasing demand for precision diagnostic and treatment options are expected to drive the 3D Imaging market in Finland.
Market Restraints
As with any medical technology, evidence-based research and assessment are required to support and verify the clinical and cost-effectiveness of 3D medical imaging. This along with other factors such as the requirement for regulatory and legal systems, data privacy concerns, high acquisition and maintenance costs for 3D Imaging technologies & shortage of skilled personnel trained to operate and interpret 3D Imaging technologies could limit the full potential of 3D Imaging in Finland.
Key Players
The Finnish Medicines Agency (Fimea) is in charge of regulating medical equipment, including 3D Imaging technology, in Finland. Fimea is in charge of evaluating medical device safety, quality, and performance, as well as granting licenses and performing inspections. Finland is also subject to the European Union's medical device regulation system, which covers 3D Imaging technology. The framework includes the Medical Devices Regulation (MDR), which went into force in May 2021.
In terms of reimbursement, the Finnish healthcare system is mostly publicly supported, with the Social Insurance Institution of Finland (Kela) managing reimbursement for medical equipment and healthcare services. Kela determines medical device reimbursement rates, based on clinical efficacy and cost-effectiveness.
1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Product (Revenue, USD Billion):
The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.
By Application (Revenue, USD Billion):
The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.
By End User (Revenue, USD Billion):
Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.
By Portability (Revenue, USD Billion):
The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.